Commission Appoints Amritha Jaishankar, Ph.D. as Executive Director, Maryland Stem Cell Research Fund (MSCRF)
The Maryland Stem Cell Research Commission announces the appointment of Amritha Jaishankar, Ph.D. as Executive Director, Maryland Stem Cell Research Fund (MSCRF). In her role as the Executive Director of the Maryland Stem Cell Research Fund, Amritha oversees all MSCRF activities and six programs accelerating stem cell research, commercialization, and cures. She will remain committed to helping our scientists, physicians, and companies advance their research and deliver cures to patients in need.
“We are delighted to appoint Dr. Amritha Jaishankar as the Executive Director of the MSCRF. Dr. Jaishankar’s leadership, dedication, and tremendous work with the MSCRF and our stem cell community over the past few years make her the ideal person to take us forward. Her unparalleled passion and sense of urgency to accelerate stem cell research and cures to patients in need will no doubt elevate MSCRF and expand its impact to benefit the people of Maryland”, said Dr. Debra Mathews, Chair of the Maryland Stem Cell Research Commission.
With over $170M in over 500 stem cell/cell therapy projects in Maryland, TEDCO leads the way in identifying and supporting the most promising stem cell technologies in our region and Amritha will continue to grow MSCRF, to expand impact and to build a collaborative stem cell community to advance science and Accelerate Cures together.
“It’s an exciting time to be in regenerative medicine and it’s been an honor to serve this community in various roles for well over a decade now. I look forward to continuing to grow and shape MSCRF, to execute our mission, and to lead the way in accelerating stem cell cures in Maryland and beyond”, said Amritha Jaishankar, Ph.D.
The Commission and MSCRF, established as an independent unit within the Maryland Technology Development Corporation (TEDCO), leads the way in identifying and supporting the most promising stem cell technologies in our region.
About The Maryland Stem Cell Research Fund (MSCRF)
The Maryland Stem Cell Research Fund (MSCRF) is focused on identifying and fostering cutting-edge research and innovation in the field of regenerative medicine in MD. Our Accelerating Cures initiative comprises programs that help transition human stem cell-based technologies from the bench to the bedside as well as mechanisms to build and grow stem cell companies in Maryland. MSCRF is committed to accelerating stem cell research, cures and commercialization, in addition to building a collaborative stem cell community in our region. Learn more about our mission and our funding opportunities at www.mscrf.org
TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland. Learn more at www.tedcomd.com.
Latest posts by Andy Eckert (see all)
- Norfolk’s ReAlta Life Sciences Receives $3.2 Million Grant from Virginia Catalyst to Accelerate Trial for the Treatment of Acute Lung Injury Due to COVID-19 - June 8, 2021
- 5 Questions with Bill Niland, CEO, ReGelTec, Inc. - June 7, 2021
- 5 Questions with Sue Carr, RPh, President and Founder, CarrTech, LLC - June 1, 2021
- 5 Questions with Elissa Cote, Chief Strategy and Business Development Officer, Mallinckrodt Pharmaceuticals - May 25, 2021
- Commission Appoints Amritha Jaishankar, Ph.D. as Executive Director, Maryland Stem Cell Research Fund (MSCRF) - May 18, 2021